MD Magazine: Condition Center: Migraine Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/conditions/migraine-resources/rss Migraine en-us Sun, 19 Aug 2018 03:43:41 +0000 Promise and Pitfalls of Preventing Migraine With CGRP Inhibitors http://www.mdmag.com/journals/md-magazine-neurology/2018/July-Neuro-2018/promise-and-pitfalls-of-preventing-migraine-with-cgrp-inhibitors http://www.mdmag.com/journals/md-magazine-neurology/2018/July-Neuro-2018/promise-and-pitfalls-of-preventing-migraine-with-cgrp-inhibitors Tue, 10 Jul 2018 11:00:00 +0000 Caffeine, Chocolate Not Associated With the Triggering of Migraine http://www.mdmag.com/medical-news/caffeine-chocolate-not-associated-with-the-triggering-of-migraine http://www.mdmag.com/medical-news/caffeine-chocolate-not-associated-with-the-triggering-of-migraine Thu, 05 Jul 2018 17:00:00 +0000 Chronic Migraine Found to More Negatively Impact Relationships, Ability to Begin Family http://www.mdmag.com/medical-news/chronic-migraine-found-to-more-negatively-impact-relationships-ability-to-begin-family http://www.mdmag.com/medical-news/chronic-migraine-found-to-more-negatively-impact-relationships-ability-to-begin-family Tue, 03 Jul 2018 15:00:00 +0000 Eptinezumab Continues Migraine Reduction Past Second Dosing in PROMISE 2 http://www.mdmag.com/medical-news/eptinezumab-continues-migraine-reduction-past-second-dosing-in-promise-2 http://www.mdmag.com/medical-news/eptinezumab-continues-migraine-reduction-past-second-dosing-in-promise-2 Mon, 02 Jul 2018 13:00:00 +0000 Eptinezumab Shows Further Migraine Reductions After Third, Fourth Infusions http://www.mdmag.com/medical-news/eptinezumab-shows-further-migraine-reductions-after-third-fourth-infusions http://www.mdmag.com/medical-news/eptinezumab-shows-further-migraine-reductions-after-third-fourth-infusions Mon, 02 Jul 2018 09:00:00 +0000 FDA Clears the Way for Phase 3 Acute Migraine Headache Trial http://www.mdmag.com/medical-news/fda-clears-the-way-for-phase-3-acute-migraine-headache-trial http://www.mdmag.com/medical-news/fda-clears-the-way-for-phase-3-acute-migraine-headache-trial Fri, 22 Jun 2018 13:46:00 +0000 Teva Pulls Out of Chronic Cluster Headache Trial of Fremanezumab http://www.mdmag.com/medical-news/teva-pulls-out-of-chronic-cluster-headache-trial-of-fremanezumab http://www.mdmag.com/medical-news/teva-pulls-out-of-chronic-cluster-headache-trial-of-fremanezumab Mon, 18 Jun 2018 16:14:00 +0000 Migraine Preventative Atogepant Met Phase 2b/3 Primary Endpoint http://www.mdmag.com/medical-news/migraine-preventative-atogepant-met-phase-2b3-primary-endpoint http://www.mdmag.com/medical-news/migraine-preventative-atogepant-met-phase-2b3-primary-endpoint Mon, 11 Jun 2018 21:52:00 +0000 From Phase 1 to FDA Approval: Following a Drug Through the Development Pipeline http://www.mdmag.com/medical-news/from-phase-1-to-fda-approval-following-a-drug-through-the-development-pipeline http://www.mdmag.com/medical-news/from-phase-1-to-fda-approval-following-a-drug-through-the-development-pipeline Thu, 07 Jun 2018 11:00:00 +0000 Galcanezumab Significantly Drops Headache Days in Adult Migraine Patients http://www.mdmag.com/medical-news/galcanezumab-significantly-drops-headache-days-in-adult-migraine-patients http://www.mdmag.com/medical-news/galcanezumab-significantly-drops-headache-days-in-adult-migraine-patients Wed, 30 May 2018 16:38:00 +0000 Erenumab Approval Ushers In New Era of Migraine Prevention Therapy http://www.mdmag.com/medical-news/erenumab-approval-ushers-in-new-era-of-migraine-prevention-therapy http://www.mdmag.com/medical-news/erenumab-approval-ushers-in-new-era-of-migraine-prevention-therapy Fri, 18 May 2018 21:05:00 +0000 FDA Approves First CGRP Inhibitor Erenumab for Migraine Prevention http://www.mdmag.com/medical-news/fda-approves-erenumab-for-migraine-prevention http://www.mdmag.com/medical-news/fda-approves-erenumab-for-migraine-prevention Fri, 18 May 2018 02:23:00 +0000 MDNN: ASD Rates Going Up, Hand Washing for C. Diff, and PROMISE 1 Results http://www.mdmag.com/news-network/mdnn-asd-rates-going-up-hand-washing-for-c-diff-and-promise-1-results http://www.mdmag.com/news-network/mdnn-asd-rates-going-up-hand-washing-for-c-diff-and-promise-1-results Fri, 04 May 2018 17:00:00 +0000 Common, Rare Variants Impact Genetic Migraine Risk http://www.mdmag.com/medical-news/common-rare-variants-impact-genetic-migraine-risk http://www.mdmag.com/medical-news/common-rare-variants-impact-genetic-migraine-risk Thu, 03 May 2018 15:00:00 +0000 Galcanezumab Reduced Monthly Migraine Headache Days for Treatment-Resistant Cases http://www.mdmag.com/conference-coverage/aan-2018/galcanezumab-reduced-monthly-migraine-headache-days-for-treatmentresistant-cases http://www.mdmag.com/conference-coverage/aan-2018/galcanezumab-reduced-monthly-migraine-headache-days-for-treatmentresistant-cases Tue, 24 Apr 2018 19:49:00 +0000 Eptinezumab Reduces Migraines Over Long-Term PROMISE 1 Results http://www.mdmag.com/conference-coverage/aan-2018/eptinezumab-reduces-migraines-over-longterm-promise-1-results http://www.mdmag.com/conference-coverage/aan-2018/eptinezumab-reduces-migraines-over-longterm-promise-1-results Tue, 24 Apr 2018 17:43:00 +0000 Non-invasive Migraine Treatment to Be Presented at AAN http://www.mdmag.com/conference-coverage/aan-2018/noninvasive-vagus-nerve-stimulation-migraine-treatment http://www.mdmag.com/conference-coverage/aan-2018/noninvasive-vagus-nerve-stimulation-migraine-treatment Fri, 20 Apr 2018 16:13:00 +0000 Erenumab Succeeds Where Other Migraine Treatments Failed http://www.mdmag.com/conference-coverage/aan-2018/erenumab-succeeds-where-other-migraine-treatments-failed http://www.mdmag.com/conference-coverage/aan-2018/erenumab-succeeds-where-other-migraine-treatments-failed Tue, 17 Apr 2018 20:28:00 +0000 Migraine Linked to Increased Risk of Cardiovascular Conditions http://www.mdmag.com/medical-news/migraine-linked-to-increased-risk-of-cardiovascular-conditions http://www.mdmag.com/medical-news/migraine-linked-to-increased-risk-of-cardiovascular-conditions Fri, 16 Feb 2018 10:00:00 +0000 Ubrogepant Reduces Pain, Symptoms in Single Migraine Attack http://www.mdmag.com/medical-news/ubrogepant-reduces-pain-symptoms-in-single-migraine-attack http://www.mdmag.com/medical-news/ubrogepant-reduces-pain-symptoms-in-single-migraine-attack Tue, 06 Feb 2018 18:26:00 +0000 Migraine More Severe Than Other Chronic Pains, But Treatable With Surgery http://www.mdmag.com/medical-news/chronic-migraine-more-severe-than-other-chronic-pains-but-treatable-with-surgery http://www.mdmag.com/medical-news/chronic-migraine-more-severe-than-other-chronic-pains-but-treatable-with-surgery Thu, 11 Jan 2018 12:00:00 +0000 Epitnezumab Meets Primary, Secondary Endpoints in PROMISE 2 http://www.mdmag.com/medical-news/epitnezumab-meets-primary-secondary-endpoints-in-promise-2 http://www.mdmag.com/medical-news/epitnezumab-meets-primary-secondary-endpoints-in-promise-2 Mon, 08 Jan 2018 18:00:00 +0000 MD Magazine's Most Read Stories of 2017 http://www.mdmag.com/medical-news/md-magazines-most-read-stories-of-2017 http://www.mdmag.com/medical-news/md-magazines-most-read-stories-of-2017 Sat, 30 Dec 2017 10:00:00 +0000 FDA Accepts BLA for Galcanezumab for Migraine Prevention http://www.mdmag.com/medical-news/fda-accepts-bla-for-galcanezumab-for-migraine-prevention http://www.mdmag.com/medical-news/fda-accepts-bla-for-galcanezumab-for-migraine-prevention Mon, 11 Dec 2017 17:47:00 +0000 Migraines Linked to High Sodium Levels in Cerebrospinal Fluids http://www.mdmag.com/medical-news/migraines-linked-to-high-sodium-levels-in-cerebrospinal-fluids http://www.mdmag.com/medical-news/migraines-linked-to-high-sodium-levels-in-cerebrospinal-fluids Mon, 04 Dec 2017 10:00:00 +0000 PROMISE 2 Explores Eptinezumab for Chronic Migraine http://www.mdmag.com/medical-news/promise-2-explores-eptinezumab-for-chronic-migraine http://www.mdmag.com/medical-news/promise-2-explores-eptinezumab-for-chronic-migraine Thu, 30 Nov 2017 21:28:00 +0000 Fremanezumab Shows Positive Results for Chronic Migraine http://www.mdmag.com/medical-news/fremanezumab-shows-positive-results-for-chronic-migraine http://www.mdmag.com/medical-news/fremanezumab-shows-positive-results-for-chronic-migraine Thu, 30 Nov 2017 20:40:00 +0000 Amgen/Novartis's Erenumab (Aimovig) Posts Positive Phase 3 Results in NEJM http://www.mdmag.com/medical-news/amgennovartiss-erenumab-aimovig-posts-positive-phase-3-results-in-nejm http://www.mdmag.com/medical-news/amgennovartiss-erenumab-aimovig-posts-positive-phase-3-results-in-nejm Thu, 30 Nov 2017 00:48:00 +0000 RedHill Biopharma Submits NDA for New Rizatriptan Formula http://www.mdmag.com/medical-news/redhill-biopharma-submits-nda-for-new-rizatriptan-formula http://www.mdmag.com/medical-news/redhill-biopharma-submits-nda-for-new-rizatriptan-formula Fri, 03 Nov 2017 15:00:00 +0000 Lilly's Lasmiditan Drastically Reduces Pain in Migraine Patients http://www.mdmag.com/medical-news/lillys-lasmiditan-drastically-reduces-pain-in-migraine-patients http://www.mdmag.com/medical-news/lillys-lasmiditan-drastically-reduces-pain-in-migraine-patients Sat, 09 Sep 2017 15:00:00 +0000